Cell analysis for hematopoietic stem/progenitor cell transplantation

被引:0
作者
Law, P
Traylor, L
Recktenwald, DJ
机构
[1] BD Biosci, San Jose, CA 95131 USA
[2] Univ Calif San Diego, Blood & Marrow Transplantat Program, La Jolla, CA USA
[3] AmCell Corp, Sunnyvale, CA USA
来源
CYTOMETRY | 1999年 / 38卷 / 02期
关键词
progenitor/stem cell subsets; cytometry; transplantation;
D O I
10.1002/(SICI)1097-0320(19990415)38:2<47::AID-CYTO1>3.0.CO;2-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cytometric analysis has become an important aspect in the quality control of cells in all phases of hematopoietic cell transplantation. In the stage of donor conditioning the counting of stem and progenitor cells is important and several reliable single platform tests for CD34+ cells have become available recently. It has been shown, that the count of certain subsets of CD34 may predict best time for harvesting stem cells better than just CD34. In many cases manipulation of the cell sample after collection from the donor is necessary before the cells are adequate for transplantation. Characterization of the resulting cell preparations requires reliable quantitative analysis of a variety of cell types like the enumeration of T-cells at the level of one in ten thousand for some allogeneic transplantations. It is discussed how these clinical requirements will need a refinement of cytometric procedures to achieve adequate clinical decisions. Cytometry (Comm. Clin. Cytometry) 38: 47-52, 1999. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:47 / 52
页数:6
相关论文
共 50 条
  • [21] Hematopoietic stem cell transplantation activity in Europe 1999
    A Gratwohl
    J Passweg
    H Baldomero
    A Urbano-Ispizua
    [J]. Bone Marrow Transplantation, 2001, 27 : 899 - 916
  • [22] Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes
    Gournay, Viviane
    Robin, Marie
    [J]. BULLETIN DU CANCER, 2023, 110 (11) : 1168 - 1175
  • [23] Hematopoietic stem cell transplantation in the treatment of autoimmune diseases
    Kozák, T
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2002, 114 (1-2) : 7 - 13
  • [24] Hematopoietic stem cell transplantation: clinical use and perspectives
    Barriga, Francisco
    Ramirez, Pablo
    Wietstruck, Angelica
    Rojas, Nicolas
    [J]. BIOLOGICAL RESEARCH, 2012, 45 (03) : 307 - 316
  • [25] Hematopoietic stem cell transplantation activity in Europe 1999
    Gratwohl, A
    Passweg, J
    Baldomero, H
    Urbano-Ispizua, A
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 (09) : 899 - 916
  • [26] Secondary malignancies after hematopoietic stem cell transplantation
    Ghelani, D
    Saliba, R
    de Lima, M
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2005, 56 (01) : 115 - 126
  • [27] Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis
    Milanetti, Francesca
    Bucha, Jurate
    Testori, Alessandro
    Burt, Richard K.
    [J]. CURRENT STEM CELL RESEARCH & THERAPY, 2011, 6 (01) : 16 - 28
  • [28] Lifetime probabilities of hematopoietic stem cell transplantation in the US
    Nietfeld, J. J.
    Pasquini, Marcelo C.
    Logan, Brent R.
    Vertei, Frances
    Horowitz, Mary M.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (03) : 316 - 322
  • [29] Heterogeneity in hematopoietic stem cell populations: implications for transplantation
    Miller, Paul H.
    Knapp, David J. H. F.
    Eaves, Connie J.
    [J]. CURRENT OPINION IN HEMATOLOGY, 2013, 20 (04) : 257 - 264
  • [30] Impact of Hematopoietic Stem Cell Transplantation on Dental Development
    Ruyssinck, Laure
    Toulouse, Kaat
    de Braem, Victoria Bordon Cueto
    Cauwels, Rita
    Dhooge, Catharina
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (01) : 107 - 113